Literature DB >> 16219546

Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion.

Gerard J Madlambayan1, Ian Rogers, Daniel C Kirouac, Nobuko Yamanaka, Frèdèric Mazurier, Monica Doedens, Robert F Casper, John E Dick, Peter W Zandstra.   

Abstract

OBJECTIVE: The absence of effective strategies for the ex vivo expansion of human hematopoietic stem cells (HSCs) limits the development of many cell-based therapies. Prior attempts to stimulate HSC expansion have focused on media supplementation using cytokines and growth factors. In these cultures, cellular and microenvironmental compositions change with time. In this study, the impact of controlling these dynamic changes on HSC output is determined.
MATERIALS AND METHODS: Cord blood-derived lin(-) cells were cultured for 8 days in serum-free medium supplemented with stem cell factor, Flt3 ligand, and thrombopoietin. Functional, phenotypic, and molecular (gene and protein) analyses were used to characterize dynamic changes in cellular and microenvironmental composition. The effects of these changes and the mechanism behind their effects on HSC expansion were assessed using a selection/media exchange-based global culture manipulation (GCM) technique.
RESULTS: We show that the direct secretion of negative regulators by culture-generated lin(+) cells, and the indirect stimulation of cells to secrete negative regulators by culture-conditioned media, limits in vitro HSC generation. The GCM strategy was able to abrogate these effects to produce elevated numbers of LTC-ICs (14.6-fold relative to input), migrating rapid NOD/SCID repopulating cells (12.1-fold), and long-term NOD/SCID repopulating cells (5.2-fold).
CONCLUSIONS: Cellular and microenvironmental changes that occur during all in vitro HSC cultures can significantly affect HSC output through the direct or indirect secretion of negative regulators. This study provides insight into the mechanisms regulating HSC fate in vitro and describes a novel methodology to regulate overall in vitro microenvironmental dynamics to enable the generation of clinically relevant numbers of HSCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219546     DOI: 10.1016/j.exphem.2005.05.018

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  18 in total

Review 1.  Hematopoietic stem cells.

Authors:  Robert G Hawley; Ali Ramezani; Teresa S Hawley
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 2.  Hematopoietic stem cell injury induced by ionizing radiation.

Authors:  Lijian Shao; Yi Luo; Daohong Zhou
Journal:  Antioxid Redox Signal       Date:  2014-02-10       Impact factor: 8.401

Review 3.  Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine.

Authors:  Patricia Flores-Guzmán; Verónica Fernández-Sánchez; Hector Mayani
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

Review 4.  Enabling stem cell therapies through synthetic stem cell-niche engineering.

Authors:  Raheem Peerani; Peter W Zandstra
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

5.  Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

Authors:  Marcos de Lima; Ian McNiece; Simon N Robinson; Mark Munsell; Mary Eapen; Mary Horowitz; Amin Alousi; Rima Saliba; John D McMannis; Indreshpal Kaur; Partow Kebriaei; Simrit Parmar; Uday Popat; Chitra Hosing; Richard Champlin; Catherine Bollard; Jeffrey J Molldrem; Roy B Jones; Yago Nieto; Borje S Andersson; Nina Shah; Betul Oran; Laurence J N Cooper; Laura Worth; Muzaffar H Qazilbash; Martin Korbling; Gabriela Rondon; Stefan Ciurea; Doyle Bosque; Ila Maewal; Paul J Simmons; Elizabeth J Shpall
Journal:  N Engl J Med       Date:  2012-12-13       Impact factor: 91.245

6.  Sustained release of stem cell factor in a double network hydrogel for ex vivo culture of cord blood-derived CD34+ cells.

Authors:  Yuanhao Zhang; Xiuwei Pan; Zhen Shi; Haibo Cai; Yun Gao; Weian Zhang
Journal:  Cell Prolif       Date:  2017-11-15       Impact factor: 6.831

7.  Inhibition of p38 mitogen-activated protein kinase promotes ex vivo hematopoietic stem cell expansion.

Authors:  Yong Wang; Joshua Kellner; Lingbo Liu; Daohong Zhou
Journal:  Stem Cells Dev       Date:  2011-02-24       Impact factor: 3.272

8.  Cell-cell interaction networks regulate blood stem and progenitor cell fate.

Authors:  Daniel C Kirouac; Gerard J Madlambayan; Mei Yu; Edward A Sykes; Caryn Ito; Peter W Zandstra
Journal:  Mol Syst Biol       Date:  2009-07-28       Impact factor: 11.429

Review 9.  Bioreactor development for stem cell expansion and controlled differentiation.

Authors:  James A King; William M Miller
Journal:  Curr Opin Chem Biol       Date:  2007-07-25       Impact factor: 8.822

10.  Bone marrow transplantation results in human donor blood cells acquiring and displaying mouse recipient class I MHC and CD45 antigens on their surface.

Authors:  Nobuko Yamanaka; Christine J Wong; Marina Gertsenstein; Robert F Casper; Andras Nagy; Ian M Rogers
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.